| Metric | Q4 2022 | Q3 2022 | Q4 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $42M | $34M | — | 24.8% | — |
| Op. Income | $12M | $10M | — | 23.8% | — |
| Gross Margin | 73.4% | 82.3% | — | -8.9pp | — |
| Net Margin | 28.6% | 21.1% | — | 7.5pp | — |
| EPS (Diluted) | $0.31 | $0.17 | — | 82.4% | — |
| Free Cash Flow | $12M | $9M | — | 26.9% | — |
| Item | Amount |
|---|---|
| REVENUE | $42M |
| Cost of Revenue | $11M |
| GROSS PROFIT | $31M |
| R&D Expenses | $0 |
| Selling & Marketing | $1M |
| General & Administrative | $15M |
| SG&A Expenses | $16M |
| Other Expenses | $3M |
| Operating Expenses | $19M |
| Cost & Expenses | $30M |
| OPERATING INCOME | $12M |
| Interest Income | $40M |
| Interest Expense | $9M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $12M |
| Income Tax Expense | $29.0K |
| Net Income from Continuing Ops | $12M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $12M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $12M |
| D&A | $631.0K |
| EBIT | $12M |
| EBITDA | $13M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $42M |
| Cost of Revenue | $11M |
| GROSS PROFIT | $31M |
| R&D Expenses | $0 |
| Selling & Marketing | $1M |
| General & Administrative | $15M |
| SG&A Expenses | $16M |
| Other Expenses | $3M |
| Operating Expenses | $19M |
| Cost & Expenses | $30M |
| OPERATING INCOME | $12M |
| Interest Income | $40M |
| Interest Expense | $9M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $12M |
| Income Tax Expense | $29.0K |
| Net Income from Continuing Ops | $12M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $12M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $12M |
| D&A | $631.0K |
| EBIT | $12M |
| EBITDA | $13M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $12M |
| Depreciation & Amortization | $631.0K |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$1M |
| Other Non-Cash Items | $3M |
| Change in Working Capital | -$395.0K |
| OPERATING CASH FLOW | $14M |
| Capital Expenditure | -$3M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$4M |
| Sales/Maturities of Investments | $74M |
| Other Investing Activities | -$287M |
| NET CASH FROM INVESTING | -$219M |
| Net Debt Issuance | $105M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $190M |
| NET CASH FROM FINANCING | $294M |
| FREE CASH FLOW | $12M |
| Net Change in Cash | $89M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $131M |
| Short-Term Investments | $245M |
| Net Receivables | $15M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $392M |
| PP&E (Net) | $35M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $3.0B |
| Tax Assets | $11M |
| Other Non-Current Assets | $153M |
| TOTAL NON-CURRENT ASSETS | $3.2B |
| TOTAL ASSETS | $3.6B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $2.9B |
| TOTAL CURRENT LIABILITIES | $2.9B |
| Long-Term Debt | $293M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $12M |
| TOTAL NON-CURRENT LIABILITIES | $305M |
| TOTAL LIABILITIES | $3.2B |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $358M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$14M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $344M |
| Minority Interest | $0 |
| TOTAL EQUITY | $344M |
| TOTAL LIABILITIES & EQUITY | $3.6B |
| Total Debt | $293M |
| Net Debt | $162M |
